Skip to main content
Tech.euFundingExplorerBeta

Antidote Technologies

Patient matching platform

Antidote Technologies has raised €33M across 3 funding rounds from 8 investors, most recently a Seed round in Jan 2026. Based in London, UK; active in Healthtech. Data as of 4 Nov 2026.

Total raised
€33M
€32,758,906
Funding rounds
3
Investors
8
distinct backers
Active since
2017-08
latest 2026-01

Funding by year

EUR raised per year · 2026 YTD
Antidote Technologies — funding by year — interactive chart.
Data table
Antidote Technologies — funding by year
2017€9.4M
2021€19M
2026€4.3M

Signals

High confidence
Raise-next likelihood46
base rate 44% for Seed
  • ▲ In typical raise window
  • ▼ Down/flat last round
  • ▼ Low backer re-investment
Exit likelihood22
base rate 11% (2+ rounds)
  • ▲ €30M+ raised
  • ▲ 9y since founding (typical exit age)
  • ▲ Recent equity round, but funding momentum is down (may be rescue financing)

Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

Similar companies

same sector, similar size

Global coverage: FundingData